Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2026-02-02 00:00:00 ET · period of report 2026-01-29 · accession 0001651691-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-01-29 | CLOV | Kuipers Peter J. | CFO | F - Tax | $2.31 | -156.9K | 5.76M | -3% | -$362.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-29 | F | D | 156,856 | $2.31 | 5,758,353 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date. |